MedPath

Comparison of Surgical Incision Complications in Patients Receiving PICO or Standard Care Following Colorectal Surgery

Not Applicable
Withdrawn
Conditions
Wounds and Injuries
Interventions
Other: Standard Care
Device: PICO Softport V1.6
Registration Number
NCT02883010
Lead Sponsor
Smith & Nephew, Inc.
Brief Summary

Surgical Site Complications (SSC's) are responsible for increased morbidity in patients undergoing surgery resulting in prolonged length of stay in the hospital while increasing treatment and hospital costs dramatically. Negative Pressure Wound Therapy (NPWT) use on closed incisions has been reported in the literature to reduce SSC's including Surgical Site Infections (SSI's), with many promising studies in general surgery, including some studies using single use NPWT. However, to date, there are very few randomised controlled trials (RCT's) using this intervention. When using PICOTM (NPWT) for this indication, patients may be discharged from hospital earlier, with the negative pressure incision management in place. This has implications in terms of cost savings for the health care system and enables the patient to be able to return to their normal daily routine more quickly. The hypothesis of this study is that PICO NPWT will reduce frequency of SSC's, in a 30 day follow up period, as compared to standard care in patients undergoing colorectal procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard careStandard CareGauze dressing, Film dressing, foam dressing, skin glue, no dressing
PICOPICO Softport V1.6Single use NPWT (PICO Softport V1.6)
Primary Outcome Measures
NameTimeMethod
Number of complications in each group30 days
Secondary Outcome Measures
NameTimeMethod
To compare PICO against Standard Care for differences in Health Related Quality of Life (HRQoL) using SF-12 over the 14-day and 30-day follow-up period30 days
Total number of readmissions during a 30-day follow-up period30 days
Dehiscence incidence during a 30-day follow-up period30 days
Total length of hospital stay, including readmissions during a 30-day follow-up period30 days
Haematoma incidence during a 30-day follow-up period30 days
Time to surgical incision closure30 days
Time to initial discharge during a 30-day follow-up period30 days
Seroma incidence during a 30-day follow-up30 days
Overall per subject treatment cost for PICO and Standard Care30 days
Cost per Quality Adjusted Life Year (QALY) within a 30-day follow-up period30 days
© Copyright 2025. All Rights Reserved by MedPath